Table of contents
January 2005 Vol 5 No 1
In this issue
p1 | doi:10.1038/nrc1551
Research Highlights
Genetic profiling: Of mice and men
p3 | doi:10.1038/nrc1540
Metastasis: One step closer
p4 | doi:10.1038/nrc1533
Carcinogenesis: Unexpected origins
p4 | doi:10.1038/nrc1535
Apoptosis: Checking in cell death
p5 | doi:10.1038/nrc1538
Viral carcinogenesis: Reactivation
p6 | doi:10.1038/nrc1531
Therapeutics: Brief encounter
p6 | doi:10.1038/nrc1541
Tumour suppressors: A new SNP
p7 | doi:10.1038/nrc1534
Stem cells: First and foremost
p8 | doi:10.1038/nrc1532
In the news
Time for a change?
p8 | doi:10.1038/nrc1537
Lymphoma: Ups and downs
p9 | doi:10.1038/nrc1539
Trial Watch
Infiltrating influence
p9 | doi:10.1038/nrc1542
Reviews
Origins of leukaemia in children with Down syndrome
Johann K. Hitzler & Alvin Zipursky
p11 | doi:10.1038/nrc1525
Osteoblasts in prostate cancer metastasis to bone
Christopher J. Logothetis & Sue-Hwa Lin
p21 | doi:10.1038/nrc1528
Galectins as modulators of tumour progression
Fu-Tong Liu & Gabriel A. Rabinovich
p29 | doi:10.1038/nrc1527
Aurora-A — A guardian of poles
Tomotoshi Marumoto, Dongwei Zhang & Hideyuki Saya
p42 | doi:10.1038/nrc1526
Integrin-linked kinase: a cancer therapeutic target unique among its ILK
Gregory Hannigan, Armelle A. Troussard & Shoukat Dedhar
p51 | doi:10.1038/nrc1524
Perspectives
Timeline
Chemotherapy and the war on cancer
Bruce A. Chabner & Thomas G. Roberts, Jr
p65 | doi:10.1038/nrc1529
Science and society
How have patient advocates in the United States benefited cancer research?
Deborah Collyar
p73 | doi:10.1038/nrc1530

